Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Nellcor Stories

2013-09-10 12:28:45

SAN ANTONIO, Sept. 10, 2013 /PRNewswire/ -- University Health System (UHS) announced today that it will strengthen patient safety measures at the medical center and in its ongoing effort to remain in the vanguard of patient safety it is converting to Nellcor(TM) pulse oximetry technology from Covidien. Oximetry non-invasively and continuously monitors the oxygen level of a patient's blood, alerting clinicians should a patient's oxygen status become compromised. Nellcor(TM) pulse...

2013-08-30 23:23:56

A live medical equipment auction will be held on Tuesday, September 10th in Las Vegas. Centurion Service Group offers online simulcast bidding, as well as theater style bidding. Las Vegas, NV (PRWEB) August 30, 2013 The world’s largest medical auction house, Centurion Service Group, will be hosting their next Las Vegas auction on September 10, 2013. The auction, which will take place at their Las Vegas location (4606 Andrews St. Suite 3, North Las Vegas, NV 89081), will feature...

2013-05-30 12:27:58

The Renewal Addresses Recent Covidien Announcements and Potential Confusion Over Pulse Oximetry Performance Crucial to Patient Care IRVINE, Calif., May 30, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI), the inventor of measure-through motion and low perfusion pulse oximetry today renewed its $1,000,000 (USD) guarantee that Masimo SET(®) Pulse Oximetry and rainbow(®) Pulse CO-Oximetry(TM) will outperform all Nellcor(TM) pulse oximeters, including the three that Covidien...

2013-05-08 16:23:20

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Maxwell Technologies Inc. (Nasdaq: MXWL) announced today that David Schlotterbeck, a seasoned medical technology executive, has been appointed to the company's board of directors. In addition, Mr. Schlotterbeck was appointed to the board's audit committee. (Logo: http://photos.prnewswire.com/prnh/20121018/LA91771LOGO) Most recently, Schlotterbeck served as chairman of the board of directors and chief executive officer of Aperio Technologies, Inc....

2013-04-17 23:01:12

Assurance Biosense, Inc announces that they have received FDA 510(k) clearance to send their unique nasal ala pulse oximetry sensor to market. Glastonbury, CT (PRWEB) April 17, 2013 Assurance Biosense Receives FDA 510(k) Clearance to Market Alar Sensor -Unique Nasal Ala Pulse Oximetry Sensor- -Alar Sensing Promises High-Levels of Accuracy, Stability and Monitoring Reliability- -Sensor Compatible with Large, Existing Installed Base of Pulse Oximeters- Assurance Biosense, Inc., a subsidiary...

2009-03-24 04:00:00

ASA Stalwart in Unresponsiveness to Patient Safety & Satisfaction Record Challenge CORONA DEL MAR, Calif., March 24 /PRNewswire/ -- The American Society of Anesthesiologists (ASA) functions much like the American Medical Association (AMA). Both publish monthly educational journals (Anesthesiology and JAMA, respectively) and express an agenda for patient safety and satisfaction. Nonetheless, both groups function primarily (and legitimately) as political organizations to represent the...

2008-09-18 12:00:40

Covidien: What: National and local experts in respiratory, pulmonary and critical care will gather for a peer-to-peer discussion about new study results and best practices. Local and national hospitals will be recognized for improvements in patient care. Keynote presentation: "Ventilator Associated Pneumonia: Prevention, Protocols, and Pay for Performance" Dr. Michael Gropper, nationally recognized critical care specialist Facilitated panel discussion highlights: -- Results...

2008-08-08 12:00:46

Covidien, a global supplier of healthcare products, has acquired technology assets from CardioDigital, a company specializing in the development of advanced signal processing techniques for patient monitoring. The technology, which will be used by Covidien's respiratory and monitoring solutions business unit, reflects the company's strong commitment to making investments in clinically relevant product innovations designed to improve patient outcomes. CardioDigital's innovative technology...

2008-08-07 09:01:05

Covidien (NYSE: COV, BSX: COV), a leading global supplier of healthcare products, today announced the acquisition of technology assets from CardioDigital Inc., a company specializing in the development of advanced signal processing techniques for patient monitoring. The technology, which will be used by Covidien's Respiratory and Monitoring Solutions business unit, reflects the Company's strong commitment to making investments in clinically relevant product innovations designed to improve...